Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Shares of Insmed Are Soaring This Week
Jim Halley
|
Sep 8, 2023
The biotech company announced positive top-line trial results and received upgrades from analysts.
Why Insmed Stock Is Soaring Today
Keith Speights
|
Sep 5, 2023
Investors applauded the company's latest clinical results.
Why QuantaSing Stock Jumped Thursday
Demitri Kalogeropoulos
|
Jun 1, 2023
Investors were happy to hear about the company's accelerating growth trends.
Why Insmed's Shares Fell 14.7% on Wednesday
Jim Halley
|
Oct 19, 2022
The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process.
Why Quanterix Stock Bounced Back on Wednesday
Eric Volkman
|
Aug 10, 2022
The market might, just might, have over-reacted to the company's dispiriting second-quarter results the previous day.
Why Quanterix Shares Plunged by Nearly 55% Today
Eric Volkman
|
Aug 9, 2022
Investors gave the thumbs-down to the biotech's latest reported quarter.
Why Nektar Therapeutics Stock Is Crashing Today
Keith Speights
|
Apr 18, 2022
The company is throwing in the towel on its lead pipeline program.
Why Nektar Therapeutics Stock Is Imploding Today
Cory Renauer
|
Mar 14, 2022
A clinical trial readout involving the company's lead candidate didn't produce the results investors were hoping for.
Why Nektar Therapeutics Stock Plunged Today
Keith Speights
|
Nov 5, 2021
The company's Q3 revenue was lower than expected.
Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Nov 5, 2021
QTRX earnings call for the period ending September 30, 2021.
View More Articles